Demand pull is outrunning the plan for one still-small offering, and the company is visibly re-pointing itself at it
The model's full reasoning — Q2 2018 call → NOWe need to determine if management describes an offering with both: (1) customer response running ahead of what company prepared for, and (2) company responding now by putting more behind it. The offering must be small relative to total business. Let's scan transcript. Antonio mentions several offerings: Intelligent Edge, HPE GreenLake, HPE Next, etc. Look for specific language about demand exceeding preparation and current response. Key candidates: HPE GreenLake (pay-per-use). Antonio says: "We saw a pickup in orders from deals that slipped from Q1 and strong customer traction from our newest offering called HPE GreenLake." That's customer traction but not necessarily ahead of preparation. Also "This is an offering we will continue to expand, look for updates soon." That's future expansion, not current. Another: Edgeline IoT Systems - "we saw strong customer traction with our Edgeline IoT Systems, including a significant win with a global financial services company." Not ahead of preparation. Another: Cape Networks acquisition - but that's acquisition, not demand. Another: HPE Next - that's cost savings, not offering. Another: Storage - but that's main business. Check for "ahead of plan" or "exceeded" language. Tim says: "revenue growth in our volume business was higher than planned" - that's about volume business (main compute), not a small offering. Also "we continue to see higher AUPs" etc. Look for "demand exceeding supply" or "capacity" - not present. Also "we are responding by putting more behind it" - e.g., adding capacity, investment. Antonio mentions "we continue to make investments to build out our Intelligent Edge portfolio" - but that's general, not specifically in response to demand exceeding preparation. Also "we will continue to expand" - future. No clear instance where both conditions are met. The closest might be HPE GreenLake but no mention of preparation gap or current expansion steps. Thus answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| ESRT | Empire State Realty Trust, Inc. | Q2 2021 | 2021-07-29 | C+ |
HCKT · Q1 2024 → YESThe question is about whether management describes one identifiable offering that's still small, where customer response is ahead of what they prepared for, AND they're responding now by putting more ...YES The transcript describes AI Explorer (the GenAI assessment platform) as a small, early-stage offering (nominal Q1 revenue impact, part of broader GenAI pivot). Management states customer response is exceeding preparation: "over 175 demo meetings with many more scheduled... resulted in a number of new enterprise...
SYY · Q1 2023 → YESThe question is about whether management describes one identifiable offering or initiative that's still a smaller part of the business, where customer response is running ahead of what they prepared f...YES The transcript shows that Sysco Your Way is presented as a smaller, still-developing offering (described as part of the Recipe For Growth pillars, with its scale expected to grow each quarter and currently limited to specific neighborhoods and recent international rollouts like Toronto and Dublin).
PRPH · Q1 2023 → YESThe question asks if management describes one identifiable offering that's still a smaller part of the business, where customer response is running ahead of what they prepared for, AND they're respond...YES The lozenge manufacturing facility is the clearest match. It is explicitly described as “the least interesting business we’re developing” and still a smaller slice of overall results (COVID testing was the dominant revenue driver for the prior two years).